ICON PLC (ICLR) Stock Price, Quote, News and Overview
NASDAQ:ICLR - Nasdaq - IE0005711209 - Common Stock - Currency: USD
ICLR Quote, Performance and Key Statistics
ICON PLC
NASDAQ:ICLR (1/30/2025, 1:43:28 PM)
202.445
+4.32 (+2.18%)
The current stock price of ICLR is 202.445 USD. In the past month the price decreased by -6.67%. In the past year, price decreased by -23.95%.
ICLR Latest News, Press Releases and Analysis
NASDAQ:ICLR is an undervalued gem with solid fundamentals.
When you look at ICON PLC (NASDAQ:ICLR), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies
ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX, NVO, and BMRN.
Clinical Research Firm ICON Faces Headwinds From Top Customers And Biotech Recovery Uncertainty
ICON forecasts 2025 revenue at $8.05 billion–$8.65 billion and adjusted EPS of $13.00–$15.00, citing biopharma spending cuts and biotech recovery delays.
ICON Issues Financial Guidance for Full Year 2025
ICLR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 28.3 | 231.99B | ||
| DHR | DANAHER CORP | 29.71 | 160.71B | ||
| A | AGILENT TECHNOLOGIES INC | 28.7 | 43.30B | ||
| IQV | IQVIA HOLDINGS INC | 18.54 | 36.54B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 35.89 | 28.89B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 51.16 | 25.05B | ||
| WAT | WATERS CORP | 36.86 | 24.93B | ||
| ILMN | ILLUMINA INC | 77.45 | 21.25B | ||
| RVTY | REVVITY INC | 26.81 | 15.43B | ||
| AVTR | AVANTOR INC | 22.67 | 15.12B | ||
| TECH | BIO-TECHNE CORP | 40.93 | 11.64B | ||
| MEDP | MEDPACE HOLDINGS INC | 30.95 | 10.99B |
Related stock screener links
About ICLR
Company Profile
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The company is headquartered in Dublin, Dublin and currently employs 42,250 full-time employees. The firm is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. The company offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The firm's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. The company also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Company Info
ICON PLC
South County Business Park, LEOPARDSTOWN, Dublin 18
DUBLIN DUBLIN 00000 IE
CEO: Steve Cutler
Employees: 42250
Company Website: https://www.iconplc.com/
Investor Relations: https://investor.iconplc.com/
Phone: 35312912000
ICLR FAQ
What is the stock price of ICLR?
The current stock price of ICLR is 202.445 USD.
What is the symbol for ICON PLC stock?
The exchange symbol of ICON PLC is ICLR and it is listed on the Nasdaq exchange.
On which exchange is ICLR stock listed?
ICLR stock is listed on the Nasdaq exchange.
Is ICLR a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ICLR, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ICLR.
Does ICLR stock pay dividends?
ICLR does not pay a dividend.
When does ICLR stock report earnings?
ICLR will report earnings on 2025-02-19, after the market close.
What is the Price/Earnings (PE) ratio of ICLR?
The PE ratio for ICLR is 14.43. This is based on the reported non-GAAP earnings per share of 14.03 and the current share price of 202.445 USD.
What is the Short Interest ratio of ICLR stock?
The outstanding short interest for ICLR is 1.92% of its float.
ICLR Technical Analysis
ICLR Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ICLR. ICLR has an average financial health and profitability rating.
ICLR Financial Highlights
Over the last trailing twelve months ICLR reported a non-GAAP Earnings per Share(EPS) of 14.03. The EPS decreased by 12.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9% | ||
| ROA | 4.35% | ||
| ROE | 7.65% | ||
| Debt/Equity | 0.35 |
ICLR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to ICLR. The Buy consensus is the average rating of analysts ratings from 26 analysts.
For the next year, analysts expect an EPS growth of 11.68% and a revenue growth 1.62% for ICLR